Determination of dabigatran, rivaroxaban and apixaban by ultra-performance liquid chromatography - tandem mass spectrometry (UPLC-MS/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulants. [electronic resource]
Producer: 20150707Description: 1636-46 p. digitalISSN:- 1538-7836
- Administration, Oral
- Anticoagulants -- administration & dosage
- Benzimidazoles -- administration & dosage
- Blood Coagulation -- drug effects
- Blood Coagulation Tests
- Calibration
- Chromatography, High Pressure Liquid
- Dabigatran
- Factor Xa Inhibitors -- chemistry
- Humans
- Morpholines -- administration & dosage
- Pyrazoles -- administration & dosage
- Pyridones -- administration & dosage
- Quality Control
- Reference Values
- Reproducibility of Results
- Rivaroxaban
- Tandem Mass Spectrometry
- Thiophenes -- administration & dosage
- beta-Alanine -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.